Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xometry (XMTR) Asset Writedowns and Impairment (2022 - 2025)

Historic Asset Writedowns and Impairment for Xometry (XMTR) over the last 4 years, with Q3 2025 value amounting to $49000.0.

  • Xometry's Asset Writedowns and Impairment changed N/A to $49000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $131000.0, marking a year-over-year decrease of 6459.46%. This contributed to the annual value of $82000.0 for FY2024, which is 7934.51% down from last year.
  • Per Xometry's latest filing, its Asset Writedowns and Impairment stood at $49000.0 for Q3 2025.
  • In the past 5 years, Xometry's Asset Writedowns and Impairment ranged from a high of $380000.0 in Q4 2022 and a low of $27000.0 during Q1 2023
  • For the 4-year period, Xometry's Asset Writedowns and Impairment averaged around $169000.0, with its median value being $135000.0 (2022).
  • Within the past 5 years, the most significant YoY rise in Xometry's Asset Writedowns and Impairment was 8403.36% (2023), while the steepest drop was 5353.85% (2023).
  • Xometry's Asset Writedowns and Impairment (Quarter) stood at $380000.0 in 2022, then tumbled by 60.26% to $151000.0 in 2023, then tumbled by 45.7% to $82000.0 in 2024, then crashed by 40.24% to $49000.0 in 2025.
  • Its last three reported values are $49000.0 in Q3 2025, $82000.0 for Q4 2024, and $151000.0 during Q3 2023.